Neogenomics Logo
Menu

Hematology solutions

Trust the experts with over 20 years of experience.

hero anchor

 

The same trusted tests you rely on, now offering broader genomic coverage, increased reporting sensitivity, and faster turnaround times

What's new:

  • Expanded guideline-driven genomic coverage: UBA1 added to support complex MDS cases
  • Expanded variant allele frequency (VAF) reporting: Hotspot mutations and 51 CHIP-associated genes are now reported at 3% VAF
  • Faster results: Comprehensive results in a single report delivered in as few as 8 days*

Comprehensive genomic profiling for hematologic malignancies

Neo Comprehensive® – Heme Cancers

Precise profiling, expert analysis & complete results

Analyzes genes associated with most hematologic malignancies from myeloid and lymphoid lineages to detect DNA and RNA alterations in one assay

Neo Comprehensive® – Myeloid Disorders

Delivering accurate results with confidence

Analyzes genes associated with most hematologic malignancies from myeloid lineages to detect DNA and RNA alterations in one assay

Explore our other testing solutions by making selections below:

Tests & services
Tests & services

Select disease state

Select modality

Cancer cells in blood

Compass®

Compass Hematopathology Services is a streamlined and personalized lab workup to help inform effective patient care management by providing diagnostic clarity to complex hematologic malignancies and prognostic and predictive information.

Ladies

The same trusted CGP myeloid results - now delivered faster

Comprehensive genomic profiling (CGP) plays a pivotal role in differentiating disease subtypes and resolving complex diagnostic challenges with greater clarity and confidence than traditional diagnostic testing. Neo Comprehensive® – Myeloid Disorders, a CGP assay, uses DNA and RNA NGS to detect relevant aberrations for diagnostic evaluation, prognosis, risk stratification, and therapy guidance for myeloid disorders with results now available in 8-11 days.

My Compass® test results provided definitive answers both on my diagnosis and my prognosis so that I could spend more time with my family.
— Dana, CLL patient

Get in touch

Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.